Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up von Fradet, Y., Bellmunt, J., Vaughn, D.J., Lee, J.L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Nam, K., Frenkl, T.L., Perini, R.F., de Wit, R., Bajorin, D.F.

Volltext

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up von Balar, A.V., Castellano, D.E., Grivas, P., Vaughn, D.J., Powles, T., Vuky, J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Necchi, A., Petrylak, D.P., Plimack, E.R., Xu, J.Z., Imai, K., Moreno, B.H., Bellmunt, J., de Wit, R., O’Donnell, P.H.

Volltext

Sleep and daily functioning during androgen deprivation therapy for prostate cancer von HANISCH, L.J., GOONERATNE, N.S., SOIN, K., GEHRMAN, P.R., VAUGHN, D.J., COYNE, J.C.

Volltext

Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen von VAUGHN, D. J, MALKOWICZ, S. B, ZOLTICK, B, MICK, R, RAMCHANDANI, P, HOLROYDE, C, ARMSTEAD, B, FOX, K, WEIN, A

Volltext

Impact of prognostic factors and risk groups on overall survival (OS) in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer (U... von Bellmunt, J., de Wit, R., Vaughn, D.J., Fradet, Y., Lee, J.L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D., Choueiri, T.K., Necchi, A., Gerritsen, W.R., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Jensen, E., Frenkl, T., Perini, R.F., Bajorin, D.

Volltext

Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas von Lee, Jason H, Whittington, Richard, Williams, Noel N, Berry, Mark F, Vaughn, David J, Haller, Daniel G, Rosato, Ernest F

Volltext

Inflammatory bowel disease is not associated with an increased risk of lymphoma von Lewis, James D., Bilker, Warren B., Brensinger, Colleen, Deren, Julius J., Vaughn, David J., Strom, Brian L.

Volltext

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma von Bellmunt, Joaquim, de Wit, Ronald, Vaughn, David J, Fradet, Yves, Lee, Jae-Lyun, Fong, Lawrence, Vogelzang, Nicholas J, Climent, Miguel A, Petrylak, Daniel P, Choueiri, Toni K, Necchi, Andrea, Gerritsen, Winald, Gurney, Howard, Quinn, David I, Culine, Stéphane, Sternberg, Cora N, Mai, Yabing, Poehlein, Christian H, Perini, Rodolfo F, Bajorin, Dean F

Volltext

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer von Vaughn, D. J.

Volltext

Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantat... von TSAI, D. E, MOORE, H. C. F, HARDY, C. L, PORTER, D. L, LOH, E. Y, VAUGHN, D. J, LUGER, S, SCHUSTER, S. J, STADTMAUER, E. A

Volltext

A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296) von Berlin, Jordan D., Adak, Sudeshna, Vaughn, David J., Flinker, David, Blaszkowsky, Lawrence, Harris, Jules E., Al Bowen Benson III, A.B.

Volltext

Recent Advances in Bladder Cancer Chemotherapy von Vaughn, David J., Malkowicz, S. Bruce

Volltext

Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics von Travis, Lois B, Fossa, Sophie D, Sesso, Howard D, Frisina, Robert D, Herrmann, David N, Beard, Clair J, Feldman, Darren R, Pagliaro, Lance C, Miller, Robert C, Vaughn, David J, Einhorn, Lawrence H, Cox, Nancy J, Dolan, M Eileen

Volltext

Eastern Cooperative Oncology Group Phase I Trial of Protracted Venous Infusion Fluorouracil Plus Weekly Gemcitabine With Concurrent Radiation Therapy in Patients With Locally Advan... von TALAMONTI, Mark S, CATALANO, Paul J, VAUGHN, David J, WHITTINGTON, Richard, BEAUCHAMP, R. Daniel, BERLIN, Jordan, III, Al B

Volltext

High-dose cytarabine neurotoxicity: MR findings during the acute phase von Vaughn, DJ, Jarvik, JG, Hackney, D, Peters, S, Stadtmauer, EA

Volltext

Paclitaxel and carboplatin in bladder cancer: recent developments von Vaughn, D.J.

Volltext

Nonsurgical management of recurrent colorectal cancer von Vaughn, David J., Haller, Daniel G.

Volltext

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen‐independent prostate carcinoma von Vaughn, David J., Brown, Archie W., Harker, W. Graydon, Huh, Sang, Miller, Lance, Rinaldi, David, Kabbinavar, Fairooz

Volltext

Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia von Malkowicz, S. Bruce, McKenna, W. Gillies, Vaughn, David J., Wan, X. Steven, Propert, Kathleen J., Rockwell, Kenneth, Marks, Sheldon H.F., Wein, Alan J., Kennedy, Ann R.

Volltext

A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-α 2a) in metastatic pancreatic carcinoma: A penn cancer clinical trials group (PCCTG) trial von DAVID, A. K, VAUGHN, D. J, HOLROYDE, C. P, ARMSTEAD, B, HALLER, D. G

Volltext